TEK and colorectal carcinoma: However, the proportion of patients without a Tie2 response (32%) was greater than that seen in our OC and CRC studies (25%), and vascular non-responders demonstrated shorter PFS (HR = 1.35, p = 0.28) than the patients treated with cytotoxic chemotherapy alone.